Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer - Wikidata - wikimedia - TriplyDB

Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer

Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer

http://www.wikidata.org/entity/Q24540132

about

Deciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast Cancer Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis Immunostaining with D2-40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancer Tumour vascularization: sprouting angiogenesis and beyond Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls.A potent, imaging adenoviral vector driven by the cancer-selective mucin-1 promoter that targets breast cancer metastasis.High lymphatic vessel density and presence of lymphovascular invasion both predict poor prognosis in breast cancer.Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth factor-C and its association with lymphangiogenesis in primary human non-small cell lung cancer Lymphangiogenesis and lymphatic metastasis in breast cancer.Clinical significance of lymph vessel density in T3 colorectal carcinoma.Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer.Inhibition of breast cancer growth and metastasis by a biomimetic peptide.Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer.Thrombocytes Correlate with Lymphangiogenesis in Human Esophageal Cancer and Mediate Growth of Lymphatic Endothelial Cells In Vitro Locoregional therapy in luminal-like and HER2-enriched patients with de novo stage IV breast cancer.Prognostic and Predictive Markers for Treatment Decisions in Early Breast Cancer Benefits and adverse effects of endocrine therapy Tumor characteristics influencing non-sentinel lymph node involvement in clinically node negative patients with breast cancer.Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early stage cancer Tumor lymphangiogenesis as a potential therapeutic target.The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer.Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.Different types of tumor vessels in breast cancer: morphology and clinical value Lymphangiogenesis and cancer Breast Cancer Subtype is Associated With Axillary Lymph Node Metastasis: A Retrospective Cohort Study.Correlation of lymphovascular invasion with clinicopathological factors in invasive breast cancer: a meta-analysis.An overview of prognostic factors for long-term survivors of breast cancer Targeting lymphangiogenesis to prevent tumour metastasis Lymphangiogenesis and lymph node metastasis in breast cancer Lithium inhibits tumor lymphangiogenesis and metastasis through the inhibition of TGFBIp expression in cancer cells First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours.Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study.Role of lymphangiogenesis in epithelial ovarian cancer.A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity Radiotherapy can improve the disease-free survival rate in triple-negative breast cancer patients with T1-T2 disease and one to three positive lymph nodes after mastectomy Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis.Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiation

P2860

Q28072448-8B0B8E5E-19AA-43A8-934C-01D6EFE19235 Q33314445-95A3692B-652D-48C3-A7F7-1D934095BB5F Q33321717-7246BB02-EF2B-4CBC-AC99-D43C543B3653 Q33428339-3A3928D2-A4E2-4AFE-BA67-3DC659C1FBC4 Q33556162-0D0CE508-151F-4794-8D66-9674BC84AC3E Q33557794-9BF97DBF-15D1-4C72-ADDA-64B9AFF14364 Q33697475-820DB4DE-132E-4989-8B9B-2E898CC07BE8 Q33702827-F47FBFF4-A8C1-458B-AA8A-266ECD53D3A2 Q33859145-5266FFCB-857C-4A36-BD16-32337DF2AEB0 Q33940058-C0BDCDD7-D1F4-4160-8E31-7A770ECCDDF2 Q34121492-E3A84ED1-F783-4A7B-B29F-9603D2FC5BCE Q34253835-52E8053B-D073-445B-9DA2-FB7C6CD15B35 Q34545644-B4A1AFA7-281D-4E60-91E0-9D9AD3E8D8CC Q34733112-D8A79638-D5C2-4135-865E-9BFD2EEA1FAC Q34806144-0072B2AE-9AF6-4464-A72F-4CB422177078 Q35059067-BD993288-128A-457F-85E2-2B5700A0EE7B Q35095603-3B178437-828A-4967-965D-03853E50CBED Q35135718-11521E84-87F0-4A8F-BBDD-897852B45348 Q35142187-AE1EF743-6984-4DF3-A99E-EE535159D168 Q35221058-8D4DAB42-DB3B-4BDE-9EEC-92505A244386 Q35769475-9F5C4546-D54B-4591-9B9D-AE1E9BEEF911 Q35838122-8E68127A-3E4C-4950-BB32-D7B1CB65F4E2 Q35954421-93940412-604D-440F-9790-017E795DF7F1 Q35984450-C25BB95A-322E-438E-A31C-6222F8C02214 Q36070111-6283E696-CF3B-4C72-A63A-76AD99F440B6 Q36137692-58FEAFCF-9533-49CB-A911-2D01C89B63AD Q36359168-8075A2E0-930B-4E97-B600-8A028F8A4C13 Q36411639-81E8194A-7E3C-4D9F-B12A-56EF1B8EA016 Q36412890-1EC80BAE-0EFA-4D70-B007-71580C55CAEC Q36461582-B74322B3-B766-4986-A169-3C67C4E2A129 Q36515990-70E7E7DE-AAE1-415C-8A9B-8D085BF0F572 Q36559874-D92BDF11-6F8F-4D2D-9B8B-54B7733995A9 Q36612618-2E095F17-81C5-463E-800B-C5A766E1322C Q36614283-3998A6FA-8BB1-488E-9E6F-26D8E5B35CC3 Q36614325-7730BF2A-A535-4465-85E4-B8B8B5D5B75D Q36614940-907D13D5-B3FA-4403-9711-3A561957E46D Q36630440-10864B8E-66B6-4DB4-BF54-218D61B78EB2 Q36779185-6845A972-90CD-4A9F-BF79-01D2ED29BE8B Q37108162-8EA3A5E3-ADFE-4E13-9B2B-E4BED669A74B Q37157775-DF929198-E711-4542-8461-0793EABFBB0E

P2860

Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer

http://www.wikidata.org/entity/Q24540132

description

2004 nî lūn-bûn

@nan

2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Prognostic value of lymphangio ...... sion in invasive breast cancer

@ast

Prognostic value of lymphangio ...... sion in invasive breast cancer

@en

Prognostic value of lymphangio ...... sion in invasive breast cancer

@nl

type

label

Prognostic value of lymphangio ...... sion in invasive breast cancer

@ast

Prognostic value of lymphangio ...... sion in invasive breast cancer

@en

Prognostic value of lymphangio ...... sion in invasive breast cancer

@nl

prefLabel

Prognostic value of lymphangio ...... sion in invasive breast cancer

@ast

Prognostic value of lymphangio ...... sion in invasive breast cancer

@en

Prognostic value of lymphangio ...... sion in invasive breast cancer

@nl

P1433

Q24540132-15446186-5E43-4F29-84EC-2A0B2F13BE8A

P1476

Q24540132-FA8D4B81-705C-45F1-8F89-E7112F9DB135

P2093

Q24540132-1D9968EE-8B37-43CD-B00F-2386AE9A04BA

Q24540132-321D9DEA-7B10-4894-9EB3-C22CE40F8C1B

Q24540132-4EE9881C-FC77-42D9-AABE-5147EB824DF2

Q24540132-593DCB94-FC9C-4808-BF3C-1F5888B4433E

Q24540132-6AFD2878-B602-447E-A784-8B7F8D1944FF

Q24540132-86EAA6DE-6D8E-4099-BB8D-59915BC01FE8

Q24540132-9E82C665-63DB-4263-A19A-C8D7B2026A83

Q24540132-B64994E4-8590-4E83-A2F6-95F43C495BC8

Q24540132-F4500B2C-C6A2-40BF-9701-DF649E32272F

Q24540132-F5E65AC7-BB82-4370-B120-DC20A74ED724

P2860

Q24540132-118A7E2B-9FBD-4F8F-B81A-BB10C042DB7F

Q24540132-21052B9D-7114-46B4-B0A0-BA36E4AC71C1

Q24540132-3102DF0E-E06C-4D47-8274-1617B8C76877

Q24540132-318573CD-EDEC-4132-AF77-EFCC5CBDA7E2

Q24540132-364EA5D4-5DD2-4CA3-8F0A-4B10EE646DC0

Q24540132-36ACF37C-342F-4A1D-81BC-43E90683FEE6

Q24540132-4D54B1F6-FB5F-4F1B-BE5B-49C23DFFA57A

Q24540132-4DA3DAD5-722E-4288-B7E3-7FF467B108D4

Q24540132-4E3B25C9-E99C-4CC9-900F-C462FFB704D3

Q24540132-5B5D52D3-5639-455F-8215-F0AF02F66DBC

P304

Q24540132-02ECD718-3CC4-4DB5-BBFB-45C18A04354B

P31

Q24540132-1D0142FE-43E2-4BF4-BF00-C6C0D81B0A61

P3181

Q24540132-598AE4BD-FA91-4775-8284-AD594C37280E

P356

Q24540132-98553DC2-C5B1-4B1C-A12E-C578FDD44226

P407

Q24540132-3FC8FA9C-FAAF-4EDF-A52A-D154CD3A6349

P433

Q24540132-0F300FFB-7847-4AB4-AAA6-C55028009E85

P478

Q24540132-699C92A0-3A85-41E5-B94A-7305E13C0594

P50

Q24540132-BBE20E30-CDAB-4FBF-A4F5-FC2AE46E2F2B

Q24540132-D5062E34-1568-4267-BD5C-E0AFA4F9B7F9

P577

Q24540132-82C33CA4-D3F6-4094-ACCE-2E94280189F6

P5875

Q24540132-3E21EFDB-1601-49E3-AF8D-A9250BE50677

P698

Q24540132-253F3666-5875-4AC3-870C-8CD6A35B24CC

P921

Q24540132-E6A32BD7-4092-4E2D-AF72-C513A0C6E6F7

P932

Q24540132-F1094FEA-8EB0-46B7-BF85-674F128BA98C

P3181

P356

01.SLA.0000133355.48672.22

P1433

Annals of Surgery

P1476

Prognostic value of lymphangio ...... sion in invasive breast cancer

@en

P2093

Austrian Breast and Colorectal Cancer Study Group

http://www.w3.org/2001/XMLSchema#string

Ernst Kubista

http://www.w3.org/2001/XMLSchema#string

Guenther Bayer

http://www.w3.org/2001/XMLSchema#string

Hellmut Samonigg

http://www.w3.org/2001/XMLSchema#string

Hubert Hausmaninger

http://www.w3.org/2001/XMLSchema#string

Klaus Aumayr

http://www.w3.org/2001/XMLSchema#string

Margaretha Rudas

http://www.w3.org/2001/XMLSchema#string

Raimund Jakesz

http://www.w3.org/2001/XMLSchema#string

Reinhard Horvat

http://www.w3.org/2001/XMLSchema#string

Silvana Geleff

http://www.w3.org/2001/XMLSchema#string

P2860

PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily

Frequency of first metastatic events in breast cancer: implications for sequencing of systemic and local-regional treatment.

Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages.

Markers for the lymphatic endothelium: in search of the holy grail?

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

Traditional and newer pathologic factors.

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review).

Molecular mechanisms of lymphangiogenesis in health and disease.

P304

306-312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

931639

http://www.w3.org/2001/XMLSchema#string

P356

10.1097/01.SLA.0000133355.48672.22

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

240

http://www.w3.org/2001/XMLSchema#string

P50

Sebastian F Schoppmann

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8435319

http://www.w3.org/2001/XMLSchema#string

P698

15273556

http://www.w3.org/2001/XMLSchema#string

P921

lymphangiogenesis

P932

1356408

http://www.w3.org/2001/XMLSchema#string